Finding a Balance In Bipolar Disorder Through Drug Prediction and Organoid-Based Drug Screening
Previous NextCircaVent is a high-throughput drug screening platform that combines predictive algorithms, preclinical models, and human brain organoids to efficiently identify and test drugs that could treat the underlying causes of bipolar disorder. CircaVent is initially focused on addressing the circadian rhythm disruptions that are a common hallmark of BD, and could dramatically speed up the process of identifying safe, effective drugs to treat a wide variety of illnesses with cognitive and behavioral effects.
Credit: Wyss Institute at Harvard University